Search

25/01/2024 RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
del Rincón, CR, Gonzalez-Martinez, A, Quintas, S, García-Azorín, D, Lázaro, IF, Guerrero-Peral, AL, Osorio, YG, Santos-Lasaosa, S, Oria, CG, Rodríguez, NS, Díez, FI, Iñiguez, AE, Luque, SG, Huerta-Villanueva, M, Díaz, SC, Muñoz-Vendrell, A, Ros, AL, Sánchez-Soblechero, A, Juanes, FV, Kortazar-Zubizarreta, I, Echeverria, A, Rodríguez-Vico, J, Sánchez, AJ, Garcia, AG, Sánchez-Mateos, NM, Belvis, R, Pérez, MPN, García-Monco, JC, Escudero, MRA, Montes, N, Gago-Veiga, AB. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine. EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(4)DOI:10.1111/ene.16203. PMID:38270379. IF:3.900(Q1/3D).
16/01/2024 New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants
Mínguez-Olaondo, A, López-Bravo, A, Quintas, S, Nieves-Castellanos, C, Layos-Romero, A, Belvís, R, Irimia, P, Díaz-Insa, S. New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants. REVISTA DE NEUROLOGIA. 2024; 78(2)DOI:10.33588/rn.7802.2023176. PMID:38223948. IF:0.800(Q4/9D).
19/12/2023 Medical help-seeking intentions among patients with early Alzheimer's disease
Villarejo-Galende, A, García-Arcelay, E, Piñol-Ripoll, G, del Olmo-Rodríguez, A, Viñuela, F, Boada, M, Franco-Macías, E, de la Peña, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodríguez-Rodríguez, E, Vieira-Campos, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Lleó, A, Maurino, J. Medical help-seeking intentions among patients with early Alzheimer's disease. Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1290002. PMID:38173708. IF:3.200(Q2/4D).
15/12/2023 Empathy as a crucial skill in disrupting disparities in global brain health
Fitri, FI, Lage, C, Mollayeva, T, Santamaria-Garcia, H, Chan, MLS, Cominetti, MR, Daria, T, Fallon, G, Gately, D, Gichu, M, Gimenez, S, Zuniga, RG, Hadad, R, Hill-Jarrett, T, O'Kelly, M, Martinez, L, Modjaji, P, Ngcobo, N, Nowak, R, Ogbuagu, C, Roche, M, Aguzzoli, CS, Shin, SY, Smith, E, Yoseph, SA, Zewde, Y, Ayhan, Y. Empathy as a crucial skill in disrupting disparities in global brain health. Frontiers in Neurology. 2023; 14DOI:10.3389/fneur.2023.1189143. PMID:38162446. IF:2.700(Q2/4D).
12/12/2023 Down Syndrome in a New Era for Alzheimer Disease
Rafii, MS, Fortea, J. Down Syndrome in a New Era for Alzheimer Disease. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023; 330(22)DOI:10.1001/jama.2023.22924. PMID:37991807. IF:63.500(Q1/1D).
05/12/2023 Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease
Acha, B, Corroza, J, de Gordoa, JSR, Cabello, C, Robles, M, Mendez-López, I, Macías, M, Zueco, S, Roldan, M, Urdánoz-Casado, A, Jericó, I, Erro, ME, Alcolea, D, Lleo, A, Blanco-Luquin, I, Mendioroz, M. Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease. NEUROLOGY. 2023; 101(23)DOI:10.1212/WNL.0000000000207865. PMID:37827850. IF:8.400(Q1/1D).
01/12/2023 Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Hirschberg, Y, Valle-Tamayo, N, Dols-Icardo, O, Engelborghs, S, Buelens, B, Vandenbroucke, RE, Vermeiren, Y, Boonen, K, Mertens, I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023; 12(12)DOI:10.1002/jev2.12383. PMID:38082559. IF:15.500(Q1/1D).
03/08/2023 Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Olazarán J., Carnero-Pardo C., Fortea J., Sánchez-Juan P., García-Ribas G., Vinuela, F, Martínez-Lage P., Boada M.. Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01271-0. PMID:37537656. IF:8.000(Q1/1D).
01/08/2023 Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid
Gagliardi, G, Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Diez, I, Lois, C, Hanseeuw, B, Schultz, AP, Properzi, MJ, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Communications Medicine. 2023; 3(1)DOI:10.1038/s43856-023-00324-7. PMID:37528163. IF:(Q/D).
26/07/2023 Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study
Hok-A-Hin, YS, Bolsewig, K, Ruiters, DN, Lleo, A, Alcolea, D, Lemstra, AW, van der Flier, WM, Teunissen, CE, del Campo, M. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023; 15(3)DOI:10.1002/dad2.12456. PMID:37502019. IF:(Q/D).
25/07/2023 Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist
Alcolea, D, Beeri, MS, Rojas, JC, Gardner, RC, Lleo, A. Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist. NEUROLOGY. 2023; 101(4)DOI:10.1212/WNL.0000000000207193. PMID:36878698. IF:8.400(Q1/1D).
31/05/2023 Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study
Aranha M.R., Coutinho A.M., Carneiro, CD, Pastorello B.F., Studart-Neto A., Guariglia C.C., Tsunemi M.H., Moreira, ELS, Ianof J.N., Anghinah R., Nitrini R., Cerri G.G., Fortea J., Buchpiguel C.A., Leite C.C.. Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study. ARQUIVOS DE NEURO-PSIQUIATRIA. 2023; 81(05)DOI:10.1055/s-0043-1768666. PMID:37257463. IF:1.000(Q4/8D).
25/05/2023 Burnout among neurologists caring for patients with cognitive disorders in Spain
Fortea, J, Garcia-Arcelay, E, Garcia-Ribas, G, Canal, N, Maurino, J. Burnout among neurologists caring for patients with cognitive disorders in Spain. PLoS One. 2023; 18(5)DOI:10.1371/journal.pone.0286129. PMID:37228146. IF:2.900(Q1/3D).
05/05/2023 Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia
Gonzalez, MC, Tovar-Rios, DA, Alves, G, Dalen, I, Williams-Gray, CH, Camacho, M, Forsgren, L, Backstrom, D, Lawson, RA, Macleod, AD, Counsell, CE, Paquet, C, DeLena, C, D'Antonio, F, Pilotto, A, Padovani, A, Blanc, F, Falup-Pecurariu, C, Lewis, SJG, Rejdak, K, Papuc, E, Hort, J, Nedelska, Z, O'Brien, J, Bonanni, L, Marquie, M, Boada, M, Pytel, V, Abdelnour, C, Alcolea, D, Beyer, K, Tysnes, OB, Aarsland, D, Maple-Grodem, J. Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia. Movement Disorders Clinical Practice. 2023; 10(6)DOI:10.1002/mdc3.13752. PMID:37332651. IF:2.600(Q2/5D).
24/04/2023 Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease
Mansilla, A, Canyelles, M, Ferrer, R, Arranz, J, Rodriguez-Baz, I, Zhu, N, Rubio-Guerra, S, El Bounasri, S, Sanchez, O, Torres, S, Fortea, J, Lleo, A, Alcolea, D, Tondo, M. Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 61(9)DOI:10.1515/cclm-2023-0245. PMID:37083158. IF:3.800(Q1/2D).
01/04/2023 Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
Montoliu-Gaya, L, Alcolea, D, Ashton, NJ, Pegueroles, J, Levin, J, Bosch, B, Lantero-Rodriguez, J, Carmona-Iragui, M, Wagemann, O, Balasa, M, Kac, PR, Barroeta, I, Llado, A, Brum, WS, Videla, L, Gonzalez-Ortiz, F, Benejam, B, Martinez, JJA, Karikari, TK, Nubling, G, Bejanin, A, Benedet, AL, Blesa, R, Lleo, A, Blennow, K, Sanchez-Valle, R, Zetterberg, H, Fortea, J. Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. EBioMedicine. 2023; 90DOI:10.1016/j.ebiom.2023.104547. PMID:37002988. IF:9.700(Q1/1D).
13/03/2023 Purpose in life promotes resilience to age-related brain burden in middle-aged adults
Abellaneda-Perez, K, Cattaneo, G, Cabello-Toscano, M, Solana-Sanchez, J, Mulet-Pons, L, Vaque-Alcazar, L, Perellon-Alfonso, R, Sole-Padulles, C, Bargallo, N, Tormos, JM, Pascual-Leone, A, Bartres-Faz, D. Purpose in life promotes resilience to age-related brain burden in middle-aged adults. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01198-6. PMID:36915148. IF:8.000(Q1/1D).
25/01/2023 Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis
Álvarez-Velasco R., Dols-Icardo O., El Bounasri S., López-Vilaró L., Trujillo J.C., Reyes-Leiva D., Suárez-Calvet X., Cortés-Vicente E., Illa I., Gallardo E.. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2)DOI:10.1212/NXI.0000000000200085. PMID:36697230. IF:8.300(Q1/1D).
01/01/2023 Caregiver knowledge of obstructive sleep apnoea in Down syndrome
Giménez S., Tapia I.E., Fortea J., Levedowski D., Osorio R., Hendrix J., Hillerstrom H.. Caregiver knowledge of obstructive sleep apnoea in Down syndrome. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH. 2023; 67(1)DOI:10.1111/jir.12990. PMID:36416001. IF:2.100(Q1/2D).
01/01/2023 Lessons from Down syndrome and autosomal dominant Alzheimer's disease
Fortea J., Quiroz Y.T., Ryan N.S.. Lessons from Down syndrome and autosomal dominant Alzheimer's disease. LANCET NEUROLOGY. 2023; 22(1)DOI:10.1016/S1474-4422(22)00437-9. PMID:36517171. IF:46.600(Q1/1D).